Amyloidogenicity and cytotoxicity of islet amyloid polypeptide
- 1 January 2001
- journal article
- review article
- Published by Wiley in Biopolymers
- Vol. 60 (6) , 438-459
Abstract
Insoluble amyloid formation by islet amyloid polypeptide (IAPP) in the islets of Langerhans of the pancreas is a major pathophysiological feature of noninsulin dependent diabetes mellitus (NIDDM) or type II diabetes. Because in vivo formed amyloid colocalizes with areas of cell degeneration and IAPP amyloid aggregates are cytotoxic per se, the process of IAPP amyloid formation has been strongly associated with the progressive pancreatic cell degeneration and thus much of the pathology of type II diabetes. IAPP is a pancreatic polypeptide of 37 residues that, in its soluble form, is believed to play a role as a regulator of glucose homeostasis. The molecular cause and mechanism of the conversion of soluble IAPP into insoluble amyloid aggregates in vivo and its role in disease progress still remain to be clarified. Nevertheless, in the past few years significant progress has been made in understanding the amyloidogenesis pathway of IAPP in vitro and gaining insight into the structural and conformational “requirements” of IAPP amyloidogenesis and related cytotoxic effects. Importantly, several of the studies have revealed significant similarities of the above features of IAPP to other amyloidogenic polypeptides such as the β‐amyloid polypeptide Aβ. This suggests that, at the molecular level, amyloidogenesis, and possibly related cell degeneration and disease pathogenesis by completely different polypeptide sequences, may obey to common structural and conformational “rules” and follow similar molecular pathways. This review describes studies on the structural and conformational features of IAPP amyloid formation and cytotoxicity, and the application of the obtained knowledge for the understanding of the molecular mechanism of the IAPP amyloidogenesis pathway and the related cytotoxicity. © 2002 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 60: 438–459, 2001Keywords
This publication has 136 references indexed in Scilit:
- Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicityJournal of Molecular Biology, 2002
- Identification of a novel human islet amyloid polypeptide β-sheet domain and factors influencing fibrillogenesisJournal of Molecular Biology, 2001
- Fibrillar Islet Amyloid Polypeptide Differentially Affects Oxidative Mechanisms and Lipoprotein Uptake in Correlation with Cytotoxicity in Two Insulin-Producing Cell LinesBiochemical and Biophysical Research Communications, 2000
- Watching amyloid fibrils grow by time-lapse atomic force microscopy 1 1Edited by W. BaumeisterJournal of Molecular Biology, 1999
- Different Sensitivity to the Cytotoxic Action of IAPP Fibrils in Two Insulin-Producing Cell Lines, HIT-T15 and RINm5F CellsBiochemical and Biophysical Research Communications, 1998
- Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitroBiochemistry, 1995
- β-Structure in Human Amylin and 2 Designer β-Peptides: CD and NMR Spectroscopic Comparisons Suggest Soluble β-Oligomers and the Absence of Significant Populations of β-Strand DimersBiochemical and Biophysical Research Communications, 1994
- AmylinLife Sciences, 1992
- Amyloid fibrils formed from a segment of the pancreatic islet amyloid proteinBiochemical and Biophysical Research Communications, 1988
- A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreasBiochemical and Biophysical Research Communications, 1986